Pancreatic Cancer Research

ResearcherWuhan Union HospitalActive in the last 2 years

Yan Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7288-9393; OpenAlex author ID A5101887301. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
17
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: 1 paper

Papers 7

  1. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis. Co-author DOI 10.1016/j.bbadis.2024.167183↗
  2. ITGA2 induces STING expression in pancreatic cancer by inducing DNMT1 degradation. Co-author DOI 10.1007/s13402-022-00731-3↗
  3. CBX3 Regulated By YBX1 Promotes Smoking-induced Pancreatic Cancer Progression via Inhibiting SMURF2 Expression. Co-author DOI 10.7150/ijbs.68995↗
  4. HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer. Co-author DOI 10.7150/thno.69444↗
  5. TRIM15 promotes the invasion and metastasis of pancreatic cancer cells by mediating APOA1 ubiquitination and degradation. Co-author DOI 10.1016/j.bbadis.2021.166213↗
  6. SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis. First author DOI 10.1016/j.canlet.2021.07.035↗
  7. Metformin activates the STING/IRF3/IFN-β pathway by inhibiting AKT phosphorylation in pancreatic cancer. Co-author PMID 33042621↗

Closest collaborators

The 17 strongest of 17 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Heshui Wu · 7 shared papers, 2020–2024 · strength 1.05
  2. Dianyun Ren · 6 shared papers, 2020–2024 · strength 0.90
  3. Xin Jin · 5 shared papers, 2020–2022 · strength 0.69
  4. Yingke Zhou · 4 shared papers, 2021–2024 · strength 0.60
  5. Jingyuan Zhao · 4 shared papers, 2020–2024 · strength 0.57
  6. Hongkun Cai · 3 shared papers, 2022–2024 · strength 0.51
  7. Gengdu Qin · 3 shared papers, 2020–2024 · strength 0.43
  8. Haixin Yu · 2 shared papers, 2022 · strength 0.29
  9. Junpeng Meng · 1 shared paper, 2022 · strength 0.19
  10. Yuhan Zhao · 1 shared paper, 2024 · strength 0.18
  11. Huan Zhang · 1 shared paper, 2022 · strength 0.15
  12. Feng Guo · 1 shared paper, 2022 · strength 0.15
  13. Zhiqiang Liu · 1 shared paper, 2021 · strength 0.15
  14. Chong Yang · 1 shared paper, 2021 · strength 0.14
  15. Penglin Pan · 1 shared paper, 2022 · strength 0.14
  16. Shikai Zhu · 1 shared paper, 2022 · strength 0.14
  17. Taoyu Chen · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.